A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)

Clinical trial NCT01407276 · COMPLETED

Trial details

NCT number: NCT01407276
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Renal Insufficiency Type 2 Diabetes Mellitus

Start date: 2011-08-08
Primary completion: 2012-03-23
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.